ArticleOpen biology2022

Characterization and structure of the human lysine-2-oxoglutarate reductase domain, a novel therapeutic target for treatment of glutaric aciduria type 1.

João Leandro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.